427 related articles for article (PubMed ID: 23027128)
1. Protein tyrosine kinase 6 protects cells from anoikis by directly phosphorylating focal adhesion kinase and activating AKT.
Zheng Y; Gierut J; Wang Z; Miao J; Asara JM; Tyner AL
Oncogene; 2013 Sep; 32(36):4304-12. PubMed ID: 23027128
[TBL] [Abstract][Full Text] [Related]
2. Protein tyrosine kinase 6 directly phosphorylates AKT and promotes AKT activation in response to epidermal growth factor.
Zheng Y; Peng M; Wang Z; Asara JM; Tyner AL
Mol Cell Biol; 2010 Sep; 30(17):4280-92. PubMed ID: 20606012
[TBL] [Abstract][Full Text] [Related]
3. Context-specific protein tyrosine kinase 6 (PTK6) signalling in prostate cancer.
Zheng Y; Tyner AL
Eur J Clin Invest; 2013 Apr; 43(4):397-404. PubMed ID: 23398121
[TBL] [Abstract][Full Text] [Related]
4. Protein tyrosine kinase 6 regulates activation of SRC kinase.
Alwanian WM; Vlajic K; Bie W; Kajdacsy-Balla A; Tyner AL
J Biol Chem; 2022 Nov; 298(11):102584. PubMed ID: 36228719
[TBL] [Abstract][Full Text] [Related]
5. Differential effect of the focal adhesion kinase Y397F mutant on v-Src-stimulated cell invasion and tumor growth.
Chang LC; Huang CH; Cheng CH; Chen BH; Chen HC
J Biomed Sci; 2005; 12(4):571-85. PubMed ID: 16132110
[TBL] [Abstract][Full Text] [Related]
6. Disruption of the mouse protein tyrosine kinase 6 gene prevents STAT3 activation and confers resistance to azoxymethane.
Gierut J; Zheng Y; Bie W; Carroll RE; Ball-Kell S; Haegebarth A; Tyner AL
Gastroenterology; 2011 Oct; 141(4):1371-80, 1380.e1-2. PubMed ID: 21741923
[TBL] [Abstract][Full Text] [Related]
7. Protein-tyrosine kinase 6 promotes peripheral adhesion complex formation and cell migration by phosphorylating p130 CRK-associated substrate.
Zheng Y; Asara JM; Tyner AL
J Biol Chem; 2012 Jan; 287(1):148-158. PubMed ID: 22084245
[TBL] [Abstract][Full Text] [Related]
8. PTK6 activation at the membrane regulates epithelial-mesenchymal transition in prostate cancer.
Zheng Y; Wang Z; Bie W; Brauer PM; Perez White BE; Li J; Nogueira V; Raychaudhuri P; Hay N; Tonetti DA; Macias V; Kajdacsy-Balla A; Tyner AL
Cancer Res; 2013 Sep; 73(17):5426-37. PubMed ID: 23856248
[TBL] [Abstract][Full Text] [Related]
9. Intestinal epithelial cancer cell anoikis resistance: EGFR-mediated sustained activation of Src overrides Fak-dependent signaling to MEK/Erk and/or PI3-K/Akt-1.
Demers MJ; Thibodeau S; Noël D; Fujita N; Tsuruo T; Gauthier R; Arguin M; Vachon PH
J Cell Biochem; 2009 Jul; 107(4):639-54. PubMed ID: 19479902
[TBL] [Abstract][Full Text] [Related]
10. v-Crk activates the phosphoinositide 3-kinase/AKT pathway by utilizing focal adhesion kinase and H-Ras.
Akagi T; Murata K; Shishido T; Hanafusa H
Mol Cell Biol; 2002 Oct; 22(20):7015-23. PubMed ID: 12242282
[TBL] [Abstract][Full Text] [Related]
11. PTK6 inhibition promotes apoptosis of Lapatinib-resistant Her2(+) breast cancer cells by inducing Bim.
Park SH; Ito K; Olcott W; Katsyv I; Halstead-Nussloch G; Irie HY
Breast Cancer Res; 2015 Jun; 17(1):86. PubMed ID: 26084280
[TBL] [Abstract][Full Text] [Related]
12. Cytoplasmic retention of protein tyrosine kinase 6 promotes growth of prostate tumor cells.
Brauer PM; Zheng Y; Wang L; Tyner AL
Cell Cycle; 2010 Oct; 9(20):4190-9. PubMed ID: 20953141
[TBL] [Abstract][Full Text] [Related]
13. v-Src rescues actin-based cytoskeletal architecture and cell motility and induces enhanced anchorage independence during oncogenic transformation of focal adhesion kinase-null fibroblasts.
Moissoglu K; Gelman IH
J Biol Chem; 2003 Nov; 278(48):47946-59. PubMed ID: 14500722
[TBL] [Abstract][Full Text] [Related]
14. Absence of adhesion triggers differential FAK and SAPKp38 signals in SW620 human colon cancer cells that may inhibit adhesiveness and lead to cell death.
Walsh MF; Thamilselvan V; Grotelueschen R; Farhana L; Basson M
Cell Physiol Biochem; 2003; 13(3):135-46. PubMed ID: 12876384
[TBL] [Abstract][Full Text] [Related]
15. Tumor necrosis factor-alpha stimulates focal adhesion kinase activity required for mitogen-activated kinase-associated interleukin 6 expression.
Schlaepfer DD; Hou S; Lim ST; Tomar A; Yu H; Lim Y; Hanson DA; Uryu SA; Molina J; Mitra SK
J Biol Chem; 2007 Jun; 282(24):17450-9. PubMed ID: 17438336
[TBL] [Abstract][Full Text] [Related]
16. Kinase-Dependent and -Independent Roles for PTK6 in Colon Cancer.
Mathur PS; Gierut JJ; Guzman G; Xie H; Xicola RM; Llor X; Chastkofsky MI; Perekatt AO; Tyner AL
Mol Cancer Res; 2016 Jun; 14(6):563-73. PubMed ID: 26983689
[TBL] [Abstract][Full Text] [Related]
17. Mammary gland specific expression of Brk/PTK6 promotes delayed involution and tumor formation associated with activation of p38 MAPK.
Lofgren KA; Ostrander JH; Housa D; Hubbard GK; Locatelli A; Bliss RL; Schwertfeger KL; Lange CA
Breast Cancer Res; 2011 Sep; 13(5):R89. PubMed ID: 21923922
[TBL] [Abstract][Full Text] [Related]
18. Focal adhesion kinase mediates the integrin signaling requirement for growth factor activation of MAP kinase.
Renshaw MW; Price LS; Schwartz MA
J Cell Biol; 1999 Nov; 147(3):611-8. PubMed ID: 10545504
[TBL] [Abstract][Full Text] [Related]
19. PTEN is a protein phosphatase that targets active PTK6 and inhibits PTK6 oncogenic signaling in prostate cancer.
Wozniak DJ; Kajdacsy-Balla A; Macias V; Ball-Kell S; Zenner ML; Bie W; Tyner AL
Nat Commun; 2017 Nov; 8(1):1508. PubMed ID: 29142193
[TBL] [Abstract][Full Text] [Related]
20. Paxillin-Y118 phosphorylation contributes to the control of Src-induced anchorage-independent growth by FAK and adhesion.
Sachdev S; Bu Y; Gelman IH
BMC Cancer; 2009 Jan; 9():12. PubMed ID: 19138410
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]